Engine shutdown: migrastatic strategies and prevention of metastases

Investor logo
Investor logo

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

RAUDENSKÁ Martina PETRLÁKOVÁ Kateřina JURIŇÁKOVÁ Tamara FIALOVÁ Jindřiška FOJTŮ Michaela JAKUBEK Milan RÖSEL Daniel BRÁBEK Jan MASAŘÍK Michal

Year of publication 2023
Type Article in Periodical
Magazine / Source Trends in Cancer
MU Faculty or unit

Faculty of Medicine

Citation
Web https://www.sciencedirect.com/science/article/pii/S2405803323000018?via%3Dihub
Doi http://dx.doi.org/10.1016/j.trecan.2023.01.001
Keywords cancer; cancer therapy; metastasis; cell migration; migrastatic therapy; mitochondria-targeting therapy; nanocarriers
Attached files
Description Most cancer-related deaths among patients with solid tumors are caused by metastases. Migrastatic strategies represent a unique therapeutic approach to prevent all forms of cancer cell migration and invasion. Because the migration machinery has been shown to promote metastatic dissemination, successful migrastatic therapy may reduce the need for high-dose cytotoxic therapies that are currently used to prevent the risk of metastatic dissemination. In this review we focus on anti-invasive and antimetastatic strategies that hold promise for the treatment of solid tumors. The best targets for migrastatic therapy would be those that are required by all forms of motility, such as ATP availability, mitochondrial metabolism, and cytoskeletal dynamics and cell contractility.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.